New in-depth report now available from 7th Annual Meeting of The International Publication Planning Association
18 September 2009, NetworkPharma Ltd, Oxford, UK have published another in their KeywordPharma series of Conference Insights Reports intended for individuals working in and around the global pharmaceutical industry.
The report of The International Publication Planning Association's 7th Annual Meeting written by Elizabeth (Liz) Wager is now available for purchase.
The reputation of publication planners continues to require defence against accusations of ghost writing and ghost management. Demands for increased transparency remain prevalent, while the age-old issue of industry sponsorship still provokes unwarranted prejudice. Companies are responding positively, with the introduction of new policies on the disclosure of results and an increased focus on compliance. However, this has, in turn, led to a diverse range of guidelines and new challenges for publication planners in interpreting them. The emergence of online communication channels such as blogs, which can often contain misinformation or imbalanced commentary, lends new complications for company communication strategies.
The International Publication Planning Association’s 7th Annual Meeting, covered in depth in this Conference Insights review, looked at the regulatory, ethical and operational challenges in publication planning, and presented an industry in transition. Beginning with an overview of the evolving regulatory frameworks for trial registration and results disclosure, and their impact on publication planning, professionals shared insights into how the industry is responding and what more can be done to enhance its reputation among health professionals and journal editors.
The meeting also explored critical issues such as risk mitigation, budget management and the issues of authorship and developments in health economic and outcomes research from the perspectives of journal editors, publication planning professionals and medical communications experts.
All KeywordPharma publications can be purchased from ThePharmYard at www.ThePharmYard.com
NOTES
About the author
Elizabeth (Liz) Wager is the author of books on Getting Research Published: An A to Z of Publication Strategy and How to Survive Peer Review. She is a co-author of Good Publication Practice For Pharmaceutical Companies and the European Medical Writers Association guidelines on the role of medical writers.
After obtaining a first-class zoology degree from Oxford in 1983, she worked for Blackwell Scientific Publications, Janssen-Cilag then Glaxo Wellcome. In 2001, she set up her own company, Sideview, which provides training, writing, editing and publication consultancy services. Since going freelance, Liz has run courses on publication strategy, medical writing and publication ethics on five continents.
She is the Chair of COPE (the Committee on Publication Ethics) and a member of: the BMJ’s Ethics Committee, the World Association of Medical Editors Ethics Committee, and the World Health Organization Scientific Advisory Group on trial registration. She is also a Visiting Fellow at the UK Cochrane Centre.
Written by pharmaceutical industry specialists, KeywordPharma publications are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development. Available to purchase individually as e-documents, they build into a specialist knowledge library for everyone working in and around the global pharmaceutical industry.
Developed and managed by NetworkPharma Ltd, ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
NetworkPharma Ltd is an independent, specialist company founded by Peter Llewellyn, to focus on novel approaches to disseminating information within the global medical and pharmaceutical industries. Peter Llewellyn previously founded and built the leading industry portal site, InPharm, which was subsequently purchased by John Wiley & Sons to manage alongside their other industry services, PharmaFile and Pharmafocus.
For more information contact:
For more information please contact us via our web site or directly contact Peter Llewellyn, Managing Director, NetworkPharma Ltd, email: peter@networkpharma.com, tel: +44 (0) 1865 865943
